Hepatitis B virus X protein suppresses caveolin-1 expression in hepatocellular carcinoma by regulating DNA methylation

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Yan, Jun ^a   Lu, Qian ^a   Dong, Jiahong ^b   Li, Xiaowu ^a   Ma, Kuansheng ^a   Cai, Lei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Caveolin 1; Hepatitis B virus X protein; Hepatocellular carcinoma; Methylation

Indexed keywords

CAVEOLIN 1; DNA; HEPATITIS B VIRUS X PROTEIN;

ARTICLE; CAVEOLIN 1 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; DOWN REGULATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; ONCOGENE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; CARCINOMA, HEPATOCELLULAR; CAVEOLIN 1; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS; TRANSFECTION;

EID: 84864946015     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-353     Document Type: Article

References (19)

1. Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C, Wang D, Sun Y, Hu G, Lang Z, Huang C, Yang X. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 2004, 39:318-324. 10.1002/hep.20076, 14767984.
2. Dewantoro O, Gani RA, Akbar N. Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53. Acta Med Indones 2006, 38:154-159.
3. Xie H, Song J, Liu K, Ji H, Shen H, Hu S, Yang G, Du Y, Zou X, Jin H, Yan L, Liu J, Fan D. The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein. Dig Dis Sci 2008, 53:3225-3233. 10.1007/s10620-008-0296-9, 18465238.
4. Gu D, Li H, Wang Z, Chen Q, Jiang J, Zhu H. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway. Laryngoscope 2007, 117:1782-1789. 10.1097/MLG.0b013e31811edd31, 17906498.
5. Lin MI, Yu J, Murata T, Sessa WC. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res 2007, 67:2849-2856. 10.1158/0008-5472.CAN-06-4082, 17363608.
6. Yan J, Lu Q, Cai L, Li XW, Dong JH. Expression of caveolin-1 gene in hepatitis B-related hepatocellular carcinoma and the clinical significance thereof. Zhonghua Yi Xue Za Zhi 2008, 88:3272-3274.
7. Yang SZ, Chen G, Zhang LD, Zhang AQ, Xiong Y, Zhu J, Li XW, Dong JH. Effects of HBx protein on the proliferation and differentiation of SMMC-7721 liver cancer cell in vitro and in vivo. Zhonghua Gan Zang Bing Za Zhi 2010, 18:713-714.
8. Chen ST, Lin SY, Yeh KT, Kuo SJ, Chan WL, Chu YP, Chang JG. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers. Int J Mol Med 2004, 14:577-582.
9. Kunze E, Von Bonin F, Werner C, Wendt M, Schlott T. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements. Int J Mol Med 2006, 17:3-13.
10. Hitchins MP, Ward RL. Erasure of MLH1 methylation in spermatozoa-implications for epigenetic inheritance. Nat Genet 2007, 39:1289. 10.1038/ng1107-1289, 17968340.
11. Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer 2007, 110:2785-2792. 10.1002/cncr.23113, 17960794.
12. Mitsuno M, Kitajima Y, Ide T, Ohtaka K, Tanaka M, Satoh S, Miyazaki K. Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients. J Gastroenterol 2007, 42:866-873. 10.1007/s00535-007-2113-1, 18008030.
13. Nakayama G, Hibi K, Kodera Y, Koike M, Fujiwara M, Nakao A. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma. Anticancer Res 2007, 27:3367-3370.
14. Kurash JK, Lei H, Shen Q, Marston WL, Granda BW, Fan H, Wall D, Li E, Gaudet F. Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell 2008, 29:392-400. 10.1016/j.molcel.2007.12.025, 18280244.
15. Zhang X, Bruice TC. Mechanism of product specificity of AdoMet methylation catalyzed by lysine methyltransferases: transcriptional factor p53 methylation by histone lysine methyltransferase SET7/9. Biochemistry 2008, 47:2743-2748. 10.1021/bi702370p, 18260647.
16. Chan TF, Su TH, Yeh KT, Chang JY, Lin TH, Chen JC, Yuang SS, Chang JG. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers. Int J Oncol 2003, 23:599-604.
17. Sunaga N, Miyajima K, Suzuki M, Sato M, White MA, Ramirez RD, Shay JW, Gazdar AF, Minna JD. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res 2004, 64:4277-4285. 10.1158/0008-5472.CAN-03-3941, 15205342.
18. Hirasawa Y, Arai M, Imazeki F, Tada M, Mikata R, Fukai K, Miyazaki M, Ochiai T, Saisho H, Yokosuka O. Methylation status of genes upregulated by demethylating agent 5-aza-2′-deoxycytidine in hepatocellular carcinoma. Oncology 2006, 71:77-85.
19. Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS, Jang KL. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 2005, 24:6617-6625. 10.1038/sj.onc.1208827, 16007161.